Patents by Inventor Oliver Meyer

Oliver Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070208204
    Abstract: A polymerization inhibitor for stabilizing olefinically unsaturated monomers containing at least one compound of formula (1) and/or (2) according to the invention. Stabilized monomer compositions.
    Type: Application
    Filed: February 5, 2007
    Publication date: September 6, 2007
    Applicant: DEGUSSA GmbH
    Inventors: Oliver Meyer, Phillip James, Oliver Erpeldinger, Frank Kraushaar
  • Patent number: 7193089
    Abstract: A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1?-methylbenzimidazol-2?-yl)benzimidazole with a compound of formula (IV) wherein Z is a leaving group, to obtain the compound 2-cyano-4?-[2?-n-propyl-4?-methyl-6?-(1??-methylbenzimidazol-2??-yl)benzimidazol-1?-ylmethyl]biphenyl, and subsequently hydrolyzing the nitrile function to obtain the acid function.
    Type: Grant
    Filed: March 17, 2004
    Date of Patent: March 20, 2007
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Norbert Hauel, Rolf Dach, Helmut Heitger, Oliver Meyer
  • Publication number: 20070038571
    Abstract: A method for transferring encrypted useful data objects (NDO) to a first telecommunication terminal (TG1) wherein at least one encrypted useful data object is initially transferred from a switching component to the first telecommunication terminal. Time information (SABS) is transferred from the switching component to the first telecommunication terminal indicating up to which moment in time a rights object (RO) associated with the at least one encrypted useful data object will arrive. Once, the rights object received by the first telecommunication terminal, the telecommunication terminal checks if the moment in time indicated in the time information has elapsed. If the moment has not elapsed, the first telecommunication terminal issues a signal relating to the receipt of a useful data object via a user interface.
    Type: Application
    Filed: October 11, 2004
    Publication date: February 15, 2007
    Inventors: Oliver Meyer, Andreas Schmidt, Markus Trauberg
  • Patent number: 7151174
    Abstract: The invention provides a process for making compounds of the general formula I: wherein R2, R4, R5, R11 and Q are defined as in claim 1. The compounds of the general formula I are effective inhibitors of HIV reverse transcriptase.
    Type: Grant
    Filed: November 1, 2005
    Date of Patent: December 19, 2006
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Oliver Meyer, Ingo Heddesheimer, Georg Zerban
  • Patent number: 7141681
    Abstract: The invention relates to a continuous process for preparing dihydropyrones of general formula I, wherein the groups R1 and R2 have the meanings described herein.
    Type: Grant
    Filed: February 14, 2002
    Date of Patent: November 28, 2006
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Oliver Meyer, Markus Sauter, Mark Goehlich
  • Patent number: 7112701
    Abstract: The present invention relates to an improved process for preparing 4-(6-bromohexyloxy)-butylbenzene by reacting 4-phenylbutanol with 1,6-dibromohexane in the presence of a base and a phase transfer catalyst, wherein 4-phenylbutanol in a diluent is metered into a mixture consisting of 1,6-dibromohexane, a base, a phase transfer catalyst and a diluent, and the use of the 4-(6-bromohexyloxy)-butylbenzene thus prepared for producing salmeterol in a method known per se.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: September 26, 2006
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Oliver Meyer, Helmut Heitger
  • Publication number: 20060100200
    Abstract: The invention provides a process for making compounds of the general formula I: wherein R2, R4, R5, R11 and Q are defined as in claim 1. The compounds of the general formula I are effective inhibitors of HIV reverse transcriptase.
    Type: Application
    Filed: November 1, 2005
    Publication date: May 11, 2006
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Oliver Meyer, Ingo Heddesheimer, Georg Zerban
  • Patent number: 7038072
    Abstract: The present invention is directed to a process for the synthesis of monoalkylated C—H acidic methylene group-containing compounds, such as malonic esters, and malonic ester nitriles.
    Type: Grant
    Filed: July 21, 2003
    Date of Patent: May 2, 2006
    Assignee: Degussa AG
    Inventors: Kerstin Bodmann, Oliver Meyer, Manfred Kaufhold, Jürgen Fieker, Renate Paulczynski
  • Patent number: 7030279
    Abstract: An alcohol can be oxidized by a process in which a primary or secondary alcohol are reacted with an oxygen-containing gas in the presence of a catalyst composition containing (i) a stable free nitroxyl radical derivative, (ii) a nitrate source, (iii) a bromide source, and (iiii) a carboxylic acid, thereby obtaining an aldehyde or a ketone.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: April 18, 2006
    Assignee: Degussa AG
    Inventors: Setrak Tanielyan, Robert Augustine, Oliver Meyer, Michael Korell
  • Publication number: 20050256312
    Abstract: A process for preparing 4-substituted 2,2,6,6-tetramethylpiperidin-N-oxy compounds (II) or mixtures of (II) and 4-substituted 2,2,6,6-tetramethylpiperidin-N-hydroxy compounds (III) where X+Y can be O or can represent a cyclic ketal with the radicals or can represent an open-chain ketal in which X?O—R and Y?O—R?, where R and R? can be identical or different and can each be CH3, CH2—CH3, CH2—CH2—CH3, CH(CH3)—CH3, CH2—CH2—CH2—CH3 and CH2—CH(CH3)—CH3, by oxidizing corresponding 4-substituted 2,2,6,6-tetramethylpiperidines (I) with hydrogen peroxide in the presence of alkali metal hydrogencarbonate and/or ammonium hydrogencarbonate and in the presence or absence of a solvent, in which the reaction is carried out with the addition of Brönsted acids which have an acid strength greater than that of the hydrogencarbonate.
    Type: Application
    Filed: May 10, 2005
    Publication date: November 17, 2005
    Applicant: Degussa AG
    Inventors: Clemens Osterholt, Heinz-Gunter Poll, Oliver Meyer, Thomas Kubelback
  • Patent number: 6958418
    Abstract: Process for preparing vanillylamine or one of the salts thereof by reacting vanillin with hydroxylamine or the salts thereof in the presence of an organic salt, which may optionally be produced in situ, wherein the reaction is carried out in an inorganic or organic acid as diluent, and subsequently hydrogenating the resulting vanillyloxime with hydrogen in the presence of a suitable catalyst and an organic and/or inorganic acid.
    Type: Grant
    Filed: June 9, 2005
    Date of Patent: October 25, 2005
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Oliver Meyer, Ingo Heddesheimer
  • Publication number: 20050171145
    Abstract: The present invention relates to a process for preparing a 2-(ethoxymethyl)-tropane derivative or a pharmaceutically acceptable salt thereof, by reacting the corresponding 2-(hydroxymethyl)-tropane derivative with ethyl bromide in the presence of a base, and a phase transfer catalyst.
    Type: Application
    Filed: January 31, 2005
    Publication date: August 4, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Richard Ehlenz, Oliver Meyer, Sascha Wagner
  • Patent number: 6916947
    Abstract: The present invention is directed to a method for producing amino acids by reacting halogenated carboxylic acid ester (haloacid esters) with a metal cyanate in the presence of an alcohol and by subsequent acidic saponification of the urethane carbonic acid formed. The method is characterized by the metal cyanate being placed at an elevated temperature in an organic solvent and the other reactants being continuously charged into the mixture over a defined time period.
    Type: Grant
    Filed: November 25, 2002
    Date of Patent: July 12, 2005
    Assignee: Degussa AG
    Inventors: Oliver Meyer, Thomas Kalz, Karlheinz Drauz
  • Publication number: 20050113608
    Abstract: The present invention relates to an improved process for preparing 4-(6-bromohexyloxy)-butylbenzene by reacting 4-phenylbutanol with 1,6-dibromohexane in the presence of a base and a phase transfer catalyst, wherein 4-phenylbutanol in a diluent is metered into a mixture consisting of 1,6-dibromohexane, a base, a phase transfer catalyst and a diluent, and the use of the 4-(6-bromohexyloxy)-butylbenzene thus prepared for producing salmeterol in a method known per se.
    Type: Application
    Filed: October 29, 2004
    Publication date: May 26, 2005
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Oliver Meyer, Helmut Heitger
  • Patent number: 6835857
    Abstract: The present invention relates to an improved process for preparing 4-(6-bromohexyloxy)-butylbenzene by reacting 4-phenylbutanol with 1,6-dibromohexane in the presence of a base and a phase transfer catalyst, wherein 4-phenylbutanol in a diluent is metered into a mixture consisting of 1,6-dibromohexane, a base, a phase transfer catalyst and a diluent, and the use of the 4-(6-bromohexyloxy)-butylbenzene thus prepared for producing salmeterol in a method known per se.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: December 28, 2004
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Oliver Meyer, Helmut Heitger
  • Publication number: 20040236113
    Abstract: A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1′-methylbenzimidazol-2′-yl)benzimidazole with a compound of formula (IV) 1
    Type: Application
    Filed: March 17, 2004
    Publication date: November 25, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Norbert Hauel, Rolf Dach, Helmut Heitger, Oliver Meyer
  • Publication number: 20040225155
    Abstract: Process for preparing vanillylamine or one of the salts thereof by reacting vanillin with hydroxylamine or the salts thereof in the presence of an organic salt, which may optionally be produced in situ, wherein the reaction is carried out in an inorganic or organic acid as diluent, and subsequently hydrogenating the resulting vanillyloxime with hydrogen in the presence of a suitable catalyst and an organic and/or inorganic acid.
    Type: Application
    Filed: June 9, 2004
    Publication date: November 11, 2004
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Oliver Meyer, Ingo Heddesheimer
  • Publication number: 20040152920
    Abstract: The invention relates to a process for ketalizing triacetonamine by reacting triacetonamine and a hydroxyl derivative, for example, a mono- or polyhydric alcohol, with gaseous hydrogen chloride to give an open-chain or cyclic ketal.
    Type: Application
    Filed: July 16, 2003
    Publication date: August 5, 2004
    Applicant: DEGUSSA AG
    Inventors: Oliver Meyer, Renate Uhlenberg, Michael Korell
  • Publication number: 20040054226
    Abstract: The present invention is directed to a process for the synthesis of monoalkylated C—H acidic methylene group-containing compounds, such as malonic esters, and malonic ester nitriles.
    Type: Application
    Filed: July 21, 2003
    Publication date: March 18, 2004
    Applicant: Degussa AG
    Inventors: Kerstin Bodmann, Oliver Meyer, Manfred Kaufhold, Jurgen Fieker, Renate Paulczynski
  • Publication number: 20030171620
    Abstract: The present invention relates to an improved process for preparing 4-(6-bromohexyloxy)-butylbenzene by reacting 4-phenylbutanol with 1,6-dibromohexane in the presence of a base and a phase transfer catalyst, wherein 4-phenylbutanol in a diluent is metered into a mixture consisting of 1,6-dibromohexane, a base, a phase transfer catalyst and a diluent, and the use of the 4-(6-bromohexyloxy)-butylbenzene thus prepared for producing salmeterol in a method known per se.
    Type: Application
    Filed: March 4, 2003
    Publication date: September 11, 2003
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Oliver Meyer, Helmut Heitger